Related Experiment Video
Updated: May 21, 2026

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
Published on: October 24, 2018
Quinacrine induced mood disturbance--the unmasking of bipolar affective disorder
John Lally1, Fintan Byrne, Elizabeth Walsh
1Department of Psychiatry, National University of Ireland, Galway (NUIG), Galway, Ireland. john.lally@nuigalway.ie
Abstract:
The authors report the case of a 20-year-old man who presented with a de novo episode of hypomania subsequent to the initiation of quinacrine for treatment resistant giardiasis. The hypomanic episode commenced some 20 days after the successful completion of a week long course of quinacrine 100 mg three times daily. The hypomanic episode was treated with olanzapine 10 mg daily. Two months subsequent to this, the patient developed a moderate depressive episode which was treated with escitalopram and olanzapine. One month after the resolution of the depressive episode, he once again presented with a hypomanic episode. The recurring episodes of discrete mood disturbance all occurred within 5 months of the commencement of quinacrine in an individual with no personal history of affective disorders.
More Related Videos
Related Concept Videos
Mania and Antimanic Drugs: Overview
Bipolar Disorder
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Depression: Overview
